Sector Focus


Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.


Sepracor, Inc. (Now Sunovion)

Sepracor Inc. was a specialty pharmaceutical company dedicated to treating and preventing human disease by discovering, developing and commercializing innovative pharmaceutical products that were directed toward serving large and growing markets and unmet medical needs. Sepracor utilized propriety single isomer technology. Their drug development program yielded a portfolio of pharmaceutical products and candidates with a focus on the treatment of respiratory and central nervous system (CNS) disorders. Their commercialization efforts were carried out by their U.S.-based primary care and specialty-oriented sales force, as well as through out-licensing partnerships.

Search Projects

  • Head, Scientific Affairs
  • Head, Formulations
  • Senior Director, Clinical Research
  • Senior Director, Regulatory Affairs (2)
  • Senior Director, Toxicology
  • Director, Clinical Operations
  • Director, Project Management
  • Director, Toxicology (2)
  • Director, Quality Assurance/Quality Control
  • Director, Clinical Pharmacology
  • Director, Strategic Healthcare and National Accounts
  • Director, Sales Force Training
  • Director, Chemical Pilot Plant
  • Director, Toxicology
  • Project Director, CNS/Urology
  • Medical Director, CNS
  • Associate Director, Clinical Operations
  • Medical Director, Urology (2)
  • Senior Project Manager
  • Project Manager, Clinical Operations
  • Director, Strategic Healthcare
  • Regional Director, Sales